期刊文献+

HPLC-MS/MS法测定全血中西罗莫司的药物浓度 被引量:2

Content determination of sirolimus in human whole blood by HPLC-MS /MS
下载PDF
导出
摘要 目的:建立简便、快速地测定人全血中西罗莫司血药浓度的HPLC-MS/MS方法。方法:全血样品经硫酸锌及含有子囊霉素(内标)的乙腈溶液沉淀后,取上清液20μL进样分析。采用Symmetry-C18色谱柱(2.1 mm×50 mm,3.5μm),流动相梯度洗脱,流速为0.5 mL.min-1,质谱采用电喷雾离子化电离源,经多反应监测模式检测。结果:西罗莫司和子囊霉素的保留时间分别为2.24 min和2.21 min,空白血浆中内源性物质不干扰测定;西罗莫司的血药浓度在1~30 ng.mL-1时,线性关系良好(r=0.999 5);日内、日间RSD值均小于10%,提取回收率为86.4%~90.4%。结论:本方法灵敏、准确、简单、快速,可用于西罗莫司的血药浓度监测和早期肝移植患者药代动力学研究。 Objective: To establish a simple and rapid HPLC-MS/MS method for determination of sirolimus in human whole blood. Methods: The samples of whole blood were deproteinated by zinc sulfate and internal standard reconstituted in acetonitrile and separated by a Symmetry-C18 column (2.1 mm × 50 mm, 3.5 μm) at the flow rate of 0.5 mL·min^-1 with gradient elution. Detection was performed on a tandem mass spectrometry with electrospray ionization source in positive ionmode. Multiple reactions monitoring mode was used to quantify sirolimus and internal standard respectively. Results: The retention time of sirolimus and intemal standard were 2.24 min and 2.21 min, respectively. The linear range of sirolimus was 1 - 30 ng-mL-1( r = 0.999 5). The intra-day and inter-day RSD were both less than 10%. The extraction recoveries were 86.4% - 90.4%. Conclusion: The method is sensitive, accurate, simple and rapid for monitoring of whole blood concentration of sirolimus and pharmacokinetic study in early liver tansplant recipients.
出处 《中国药物应用与监测》 CAS 2013年第4期206-208,共3页 Chinese Journal of Drug Application and Monitoring
关键词 西罗莫司 高效液相色谱质谱联用 血药浓度 Sirolimus HPLC-MS/MS Blood concentration
  • 相关文献

参考文献7

二级参考文献60

  • 1杜雨,周冬燕,胡永秀.西罗莫司的作用机制及应用研究进展[J].国外医学(药学分册),2005,32(4):250-253. 被引量:4
  • 2祝仕清,牛长群,耿亚鹏.UPLC(超高效液相色谱)/MS/MS联用技术测定全血中的西罗莫司[J].中国抗生素杂志,2007,32(6):347-349. 被引量:9
  • 3HARDMAN J G, LIMBIRD L E. Goodman & Gilman'S Pharmacological Basis of Therapeutics(古德曼·吉德曼 治疗学的药理学基础) [M]. Tenth Edition Beljing: People's medical publishing House, 2002:1339.
  • 4VICENTE F B, SMITH F A, PENG Y,et al. Evaluatian of an immunoassay of whole blood sirolimus in pediatric transplant patients in comparison with high-performance liquid chromatugraphy/tandem mass spectrometry [ J ]. Clin Chem Lab Med, 2006,44 ( 4 ) :497 -499.
  • 5BORROWS R, CHUSNEY G, LOUCAIDOU M, et al. Tacrolimus monitoring in renal transplantation: a comparison between high- performance liquid chromatography and immunoassay [ J ] .Transplant Proc,2005,37(4) :1733-1735.
  • 6SALM P, TAYLOR P J, LYNCH S V, et al. A rapid HPLC-mass spectrometry cyclosporln method suitable for current monitoring practices [ J ]. Clin Biochem,2005,38 ( 7 ) :667-673.
  • 7RAYMOND G M. Immunosuppressant drag monitoring: is the labortary meeting clinical expections? [ J ]. Transplantation ,2005, 39(1) :119-127.
  • 8Morales JM, Wramner L, Kreis H, et al. Sirolimus does not exhibit nephrotoxicity compared to cyclosporine in renal transplant recipients[J]. Am J Transplant,2002,2(5) :436-442.
  • 9Sehgal SN, Rapamune (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression [J]. Clin Biochem,2006,39(5):484-489.
  • 10Fung J, Kelly D, Kadry Z, et al. Immunosuppression in liver transplantation: beyond ca|cineurin inhibitors[J]. Liver Transpl, 2005 : 11 (3) : 267-280.

共引文献14

同被引文献16

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部